Skip to content

This website is intended for pharmaceutical trade partners, distributors and registered medical practitioners in India. It is not intended for patients or the general public.

Product range

Respiratory range

Every brand we market, with its composition, pack and maximum retail price. Trade rates are shared with partners holding a valid drug licence and GSTIN.

Showing 7 of 7 brands

Our product range: brand name, composition, packing, dosage form and maximum retail price.
BrandCompositionMRP ₹
BILAZEN 20
Schedule H
1*10 · Tablet
Bilastine 20mg
Respiratory
154.00
BILAZEN M
Schedule H
1*10 · Tablet
Bilastine 20mg+Montelukast 10mg
Respiratory
135.93
CLENBRO ACE
Schedule H
1*10 · Tablet
N- Acetylcysteine 600mg+Acebrophylline 100mg
Respiratory
250.00
DANBRO 200 SR
Schedule H
1*10 · Tablet
Acebrophylline 200mg
Respiratory
285.00
MONTRIL FX
Schedule H
1*10 · Tablet
Montelukast 10mg+Fexofenadine 120mg
Respiratory
185.00
MONTRIL LC
Schedule H
1*10 · Tablet
Montelukast 10mg+Levocetirizine 5mg
Respiratory
145.31
NANOLEVO 5
Schedule H
1*10 · Tablet
Levocetirizine 5mg
Respiratory
35.00

Figures shown are maximum retail price, inclusive of all taxes. Trade rates (PTR and PTS) and product literature are shared with distribution partners holding a valid drug licence and GSTIN.

Request the rate list

A pharmaceutical marketing company appointing distribution partners across India. Our range is manufactured at the WHO-GMP certified facilities of our manufacturing partners.

Company information

Registered name
CLENTIS PHARMACEUTICAL PRIVATE LIMITED
CIN
U46497UP2024PTC208662
Registered office
II-A/98/G-1, Vaishali, Ghaziabad, Uttar Pradesh 201010, India
Telephone
+91 6397-047026
Email
info.clentis@gmail.com
Support
support.clentis@gmail.com
GSTIN
05AAMCC0984E1ZP

We do not sell medicines online. Products are supplied only to holders of a valid drug licence and GSTIN. Prescription medicines are to be sold by retail only on the prescription of a Registered Medical Practitioner. Nothing on this website is medical advice.